Both Icahn School of Medicine at Mount Sinai and CMLS Holdings LLC filed Form 4s for a combined amount of $40 million in GeneDx Holdings Corp $WGS.

Activist investor and retail industry entrepreneur...

The most significant insider buy on today’s list is a Form 4 filing by Greg Hayes, the CEO of Raytheon Technologies $RTX.

Hayes reported a purchase of roughly $1 million in Phillips 66 $PSX, where he serves as a director.

The largest insider buy on today's list is a Form 4 filing by Steve Miron,  director at Charter Communications $CHTR.

Miron revealed the purchase of $960,875 worth of CHTR shares.

The largest insider buy on today's list is a Form 4 filing by Randal Kirk, the executive chairman of Precigen $PGEN.

Kirk revealed the purchase of roughly $20 million of his own stock from him, increasing his ownership stake to 46.2%.

The largest insider buy on today’s list is a Form 4 filing by CD&R Boulder Holdings LP.

The firm revealed a purchase of approximately $6 million worth of shares in Beacon Roofing Supply $BECN.

From the desk of Steve Strazza @Sstrazza

Check out this week's Momentum Report, our weekly summation of all the major indexes at a Macro, International, Sector, and Industry Group level.

By analyzing the short-term...

From the desk of Steve Strazza @Sstrazza

Our Top 10 Charts Report was just published.

In this weekly note, we highlight 10 of the most important charts or themes we’re currently seeing in asset classes around the world.

The most significant insider buy on today's list is a Form 4 filing by Abdiel Capital Advisors.

The hedge fund reported a purchase of $4.8 million in Appian Corporation $APPN.

The most significant insider buy on today’s list is a Form 4 filing by Lockheed Martin $LMT Director John Donovan.

Donovan reported a purchase of roughly $250,867 in LMT.

Today's Hot List is another short one.

The only 13G on our list was filed by Pura Vida Investments LLC, which revealed an initial stake of 5.62% in Quanterix Corporation $QTRX.

The largest insider buy on today's list is a Form 4 filing by RA Capital Management.

The hedge fund reported a purchase of roughly $25 million in Fulcrum Therapeutics Inc $FULC, increasing its ownership stake to 23.8%.

From the Desk of Steve Strazza @Sstrazza

Last week we held our January Monthly Conference Call, which Premium Members can access and rewatch...

From the desk of Steve Strazza @Sstrazza

Our Top 10 Charts Report was just published.

In this weekly note, we highlight 10 of the most important charts or themes we’re currently seeing in asset classes around the world.

The largest insider buy on today's list is a Form 4 filing by EcoR1 Capital LLC, which reported a purchase of roughly $2.9 million in Zymeworks Inc $ZYME.

EcoR1 Capital also filed a Form 13G, disclosing a stake of 7.80% in the cancer biotech...